Cargando…
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration
The aim of this cross‐sectional study was to examine whether a history of selective estrogen receptor modifiers (SERMs), tamoxifen and raloxifene, use was associated with cognitive performance, odds of mild cognitive impairment (MCI), or magnetic resonance imaging (MRI) markers of neurodegeneration...
Autores principales: | Kara, Firat, Lohse, Christine M., Castillo, Anna M., Tosakulwong, Nirubol, Lesnick, Timothy G., Jack, Clifford R., Petersen, Ronald C., Olson, Janet E., Couch, Fergus J., Ruddy, Kathryn J., Kantarci, Kejal, Mielke, Michelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939086/ https://www.ncbi.nlm.nih.gov/pubmed/36040183 http://dx.doi.org/10.1002/cam4.5175 |
Ejemplares similares
-
Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study
por: Beyer, Joana, et al.
Publicado: (2023) -
Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration
por: Zeydan, Burcu, et al.
Publicado: (2018) -
Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial
por: Kantarci, Kejal, et al.
Publicado: (2018) -
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
por: Kantarci, Kejal, et al.
Publicado: (2016) -
A novel computer adaptive word list memory test optimized for remote assessment: Psychometric properties and associations with neurodegenerative biomarkers in older women without dementia
por: Stricker, Nikki H., et al.
Publicado: (2022)